GRAIL, Inc. Files 8-K on Financials

Ticker: GRAL · Form: 8-K · Filed: Jan 15, 2025 · CIK: 1699031

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

GRAIL filed its 8-K on Jan 15, 2025, detailing financial condition and results of operations.

AI Summary

GRAIL, Inc. filed an 8-K on January 15, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's operational and financial status as of January 15, 2025.

Why It Matters

This 8-K filing provides crucial updates on GRAIL, Inc.'s financial performance and operational status, which can influence investor decisions and market perception.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative or positive material events.

Key Players & Entities

FAQ

What specific items are included in the 'Results of Operations and Financial Condition' section of the 8-K?

The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details within these sections are not provided in the provided text.

What is GRAIL, Inc.'s IRS Employer Identification Number?

GRAIL, Inc.'s IRS Employer Identification Number is 86-3673636.

When was GRAIL, Inc. incorporated and in what jurisdiction?

GRAIL, Inc. was incorporated in Delaware.

What is the SEC File Number for GRAIL, Inc.?

The SEC File Number for GRAIL, Inc. is 001-42045.

What is the address of GRAIL, Inc.'s Principal Executive Offices?

The address of GRAIL, Inc.'s Principal Executive Offices is 1525 O'Brien Drive, Menlo Park, California 94025.

Filing Stats: 533 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-15 12:00:21

Key Financial Figures

Filing Documents

02

Item 2.02 Results of operations and financial condition. On January 15, 2025, GRAIL, Inc. (the "Company") plans to present a corporate update and preliminary financial information for the quarter and year ended December 31, 2024 at the 2025 J.P. Morgan Healthcare Conference. A copy of the presentation that will be used is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Item 2.02 of this Current Report on Form 8-K and the exhibit attached hereto are intended to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Except as shall be expressly set forth by specific reference in such filing, the information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

01

Item 9.01 Exhibits (d) Exhibits. 99.1 Presentation of GRAIL, Inc. dated January 15, 2025.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GRAIL, INC. Date: January 15, 2025 By: /s/ Aaron Freidin Name: Aaron Freidin Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing